These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 213489)

  • 41. Direct activation of complement by trypanosomes.
    Sheppard J; Nielsen K; Tizard I; Holmes W
    J Parasitol; 1978 Jun; 64(3):544-6. PubMed ID: 351160
    [No Abstract]   [Full Text] [Related]  

  • 42. Studies on the FMR antigen.
    Lilly F; Nathenson SG
    Transplant Proc; 1969 Mar; 1(1):85-9. PubMed ID: 4332534
    [No Abstract]   [Full Text] [Related]  

  • 43. Cooperative binding of a complement component to antigen-antibody complexes. III. Complexes containing IgM antibodies.
    Kuo CY; Thompson JJ; Hoffmann LG
    Z Immunitatsforsch Immunobiol; 1976 Sep; 152(2):151-66. PubMed ID: 960974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of a receptor for complement on the guinea pig alveolar macrophage membrane.
    Whitcomb ME
    Am Rev Respir Dis; 1978 Aug; 118(2):431-3. PubMed ID: 697192
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hydrolysis of a synthetic amide substrate by human C1 esterase (C1s).
    Morgan PH; Nair IG
    J Immunol; 1977 Jul; 119(1):19-25. PubMed ID: 17638
    [No Abstract]   [Full Text] [Related]  

  • 46. Interactions between mycoplasma pneumoniae and the first components of complement.
    Bredt W; Wellek B; Brunner H; Loos M
    Infect Immun; 1977 Jan; 15(1):7-12. PubMed ID: 832909
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interactions of C-reactive protein with the first component of human complement.
    Claus DR; Siegel J; Petras K; Osmand AP; Gewurz H
    J Immunol; 1977 Jul; 119(1):187-92. PubMed ID: 17637
    [No Abstract]   [Full Text] [Related]  

  • 48. Guinea pig L2C leukemia: immunological, virological and clinical aspects: introduction.
    Rhim JS; Green I
    Fed Proc; 1977 Aug; 36(9):2247-8. PubMed ID: 195844
    [No Abstract]   [Full Text] [Related]  

  • 49. Purification of the first component of guinea-pig complement by gel chromatography.
    Lyberg T
    Acta Pathol Microbiol Scand C; 1978 Dec; 86C(6):283-9. PubMed ID: 103366
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunological relationships of an endogenous guinea pig retrovirus with prototype mammalian type B and type D retroviruses.
    Dahlberg JE; Tronick SR; Aaronson SA
    J Virol; 1980 Jan; 33(1):522-30. PubMed ID: 6154150
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies of the binding of human and guinea pig C1 to human and guinea pig lymphocytes.
    Richardson AK; Sargent AU
    Immunol Commun; 1980; 9(6):577-93. PubMed ID: 7429531
    [No Abstract]   [Full Text] [Related]  

  • 52. The catabolism of intact, reactive centre-cleaved and proteinase-complexed C1 inhibitor in the guinea pig.
    Malek R; Aulak KS; Davis AE
    Clin Exp Immunol; 1996 Jul; 105(1):191-7. PubMed ID: 8697630
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autocatalytic activation of the proenzyme form of the C1s subunit of the first component of complement.
    Morgan PH; Nair IG
    Biochem Biophys Res Commun; 1975 Oct; 66(3):1037-41. PubMed ID: 1180942
    [No Abstract]   [Full Text] [Related]  

  • 54. Fixation of frog and guinea pig complement by antibodies from the bullfrog, Rana catesbeiana.
    Alexander RJ; Steiner LA
    Mol Immunol; 1980 Oct; 17(10):1263-73. PubMed ID: 6970331
    [No Abstract]   [Full Text] [Related]  

  • 55. Complement-mediated lysis of type-C virus: effect of primate and human sera on various retroviruses.
    Sherwin SA; Benveniste RE; Todaro GJ
    Int J Cancer; 1978 Jan; 21(1):6-11. PubMed ID: 75191
    [No Abstract]   [Full Text] [Related]  

  • 56. Morphological evidence for the presence of the endogenous guinea-pig retravirus in the lymphoblasts of L2C leukemia.
    Perk K; Dahlberg JE
    Experientia; 1979 Jan; 35(1):104-5. PubMed ID: 283931
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The NH-2-terminal sequences of a subunit of the first component of human complement, C1s, and its activated form, C1s.
    Takahashi K; Nagasawa S; Koyama J
    FEBS Lett; 1975 Feb; 50(3):330-3. PubMed ID: 1116603
    [No Abstract]   [Full Text] [Related]  

  • 58. Difference in dose response between native and activated first component of guinea pig complement (C1): reaction with C1 inactivator offers no explanation.
    Hoffmann IG; Stevland NP
    Immunochemistry; 1971 Jun; 8(6):499-508. PubMed ID: 5570045
    [No Abstract]   [Full Text] [Related]  

  • 59. Tracing complement-retroviral interactions from mucosal surfaces to the lymphatic tissue.
    Banki Z; Soederholm A; Mullauer B; Dierich MP; Stoiber H
    Front Biosci; 2007 Jan; 12():2096-106. PubMed ID: 17127447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluid phase destruction of C2hu by C1hu. I. Its enhancement and inhibition by homologous and heterologous C4.
    Gigli I; Austen KF
    J Exp Med; 1969 Apr; 129(4):679-96. PubMed ID: 5766946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.